Postmenopausal bleeding uterine cancer — Dr. Nishtha Tripathi Patel is an ESGO-certified gynaecological oncosurgeon offering specialist consultations and surgical care at Sterling Hospitals, KD Hospital and Welcare Speciality Hospital in Ahmedabad. This page covers postmenopausal bleeding uterine cancer for patients, families and referring doctors looking for evidence-based, India-context information.
On this page
- The Symptom That Should Never Be Ignored
- Risk Factors for Endometrial Cancer
- How Is It Investigated?
- Premenopausal Women Are Not Immune
Postmenopausal bleeding uterine cancer — The Symptom That Should Never Be Ignored
Postmenopausal bleeding — any vaginal bleeding that occurs 12 or more months after the last menstrual period — is the presenting symptom in approximately 90% of uterine (endometrial) cancer cases. This means most uterine cancers are diagnosed early, when cure rates are highest. The challenge is that many women delay seeking assessment, reassured by the fact that most causes of postmenopausal bleeding are benign.
While the majority of cases (approximately 70–90%) will turn out to be due to atrophic vaginitis, endometrial atrophy, polyps, or fibroids, the clinical rule is clear: all postmenopausal bleeding requires investigation until endometrial malignancy has been excluded.
Risk Factors for Endometrial Cancer
- Obesity — adipose tissue converts androgens to oestrogen; excess oestrogen unopposed by progesterone is the primary driver of most endometrial cancers
- Diabetes and insulin resistance
- Nulliparity (never having been pregnant)
- Late menopause (after age 55)
- Oestrogen-only hormone replacement therapy in women with an intact uterus
- Tamoxifen use for breast cancer (weakly oestrogenic effect on the endometrium)
- Lynch syndrome (hereditary non-polyposis colorectal cancer) — the highest-risk hereditary syndrome for endometrial cancer
How Is It Investigated?
Investigation begins with a transvaginal ultrasound (TVUS), which measures the endometrial thickness. An endometrial stripe of 4 mm or less in a postmenopausal woman is reassuring; values above this threshold warrant further investigation with an endometrial biopsy — a 5-minute outpatient procedure. In some cases a hysteroscopy (direct visualisation of the uterine cavity) is needed to obtain a targeted biopsy.
If endometrial cancer is confirmed on biopsy, an MRI of the pelvis and a CT of the thorax/abdomen/pelvis is arranged to assess depth of myometrial invasion and any lymph node spread before surgical planning.
Premenopausal Women Are Not Immune
Although endometrial cancer is primarily a postmenopausal disease (median age 63 at diagnosis), premenopausal women — particularly those who are obese, have polycystic ovarian syndrome, or have Lynch syndrome — can also develop it. Persistent abnormal uterine bleeding in a premenopausal woman over 40 should also be investigated.
The key message: do not normalise abnormal uterine bleeding. It deserves evaluation.
Dr. Nishtha Tripathi Patel is a gynaecological oncologist in Ahmedabad specialising in uterine, ovarian, and cervical cancers. Contact: +91 76988 00333.
Further Reading & Sources
Related Pages on This Site
Consultation and Next Steps
For an individualised consultation on postmenopausal bleeding uterine cancer, share your reports on WhatsApp at +91 76988 00333. Dr. Nishtha Tripathi Patel provides a detailed assessment within 24-48 hours and arranges in-person consultation at Sterling Hospitals, KD Hospital, or Welcare Speciality Hospital in Ahmedabad based on your location and treatment requirements.
Bring the following to your first consultation: imaging studies (ultrasound, CT or MRI on CD), histopathology and biopsy reports, tumour marker results (CA-125, HE4, CEA where relevant), a list of current medications, and any prior treatment summaries. For patients travelling from outside Ahmedabad, scheduling can be arranged to complete consultation and any pre-op work-up in the fewest possible visits.
If you are exploring second-opinion options, see our second-opinion service page. Independent review of diagnosis, staging, and proposed treatment plans is provided at no cost via WhatsApp report review. You do not need to switch hospitals to obtain a second opinion.
For broader information about postmenopausal bleeding uterine cancer and related conditions, also see our complete ovarian cancer guide, HIPEC India guide, cervical cancer guide and robotic surgery guide.